StreetInsider.com News Articles

Trump's CDC nominee to exit UnitedHealth, divest holdings

Mon, 22 Jun 2026 15:03:08 -0400

Investing.com -- Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will resign from UnitedHealth and sell healthcare-related holdings if confirmed, according to a financial disclosure to the HHS Ethics counsel dated June 16.

Schwartz's employment with UnitedHealth Group will end upon confirmation. She will receive a cash payment equal to one year's salary and a bonus before assuming the CDC role, or forfeit the money if she does not take the position.

UnitedHealth agreed to cash out certain unvested restricted stock units and unvested stock options that would otherwise have vested between August 2026

UnitedHealth Group (UNH) PT Lowered to $197 at TD Cowen

Mon, 22 Jun 2026 09:58:24 -0400

TD Cowen analyst Ryan Langston lowered the price target on UnitedHealth Group (NYSE: UNH) to $197.00 (from $230.00) while maintaining a Buy rating.

The analyst commented: "Lower Core Growth + BH Licensure H/W, Adding Benefit from FL SDP; Given the results from our May 2026 Hospital Survey showing ~flat yty revenue, recent commentary from ARDT (not covered), public MCO commentary and remarks made at our 2nd Annual Hospital Summit (here), we are lowering our core growth estimates for 2026/27. We also model BH Laurel Ridge impact and include FL DPP in 2Q26 ests (but not in 2027). Our PT moves to

UnitedHealth Group (UNH) PT Lowered to $197 at TD Cowen

Mon, 22 Jun 2026 09:58:24 -0400

TD Cowen analyst Ryan Langston lowered the price target on UnitedHealth Group (NYSE: UNH) to $197.00 (from $230.00) while maintaining a Buy rating.

UnitedHealth Group (UNH) PT Raised to $462 at Leerink

Wed, 17 Jun 2026 06:19:35 -0400

Leerink analyst Whit Mayo raised the price target on UnitedHealth Group (NYSE: UNH) to $462.00 (from $400.00) while maintaining a Outperform rating.

The analyst comments "Reiterate Outperform rating. We raise our 2027-28 EPS forecasts to align with recent management commentary on the pace of margin recovery for Optum Health as well as higher conviction on the stability of trend. Assuming UNH can get back into targeted margins by 2028, we could easily see an upside case for $30/share of EPS. That implies UNH is trading sub-14x and what we see as still a compelling valuation despite the run-up. In our view,

UnitedHealth Group (UNH) PT Raised to $462 at Leerink

Wed, 17 Jun 2026 06:19:35 -0400

Leerink analyst Whit Mayo raised the price target on UnitedHealth Group (NYSE: UNH) to $462.00 (from $400.00) while maintaining a Outperform rating.

UnitedHealth Group (UNH) PT Raised to $462 at Leerink

Wed, 17 Jun 2026 06:19:35 -0400

Leerink analyst Whit Mayo raised the price target on UnitedHealth Group (NYSE: UNH) to $462.00 (from $400.00) while maintaining a Outperform rating.

AdvancedMD Gives Independent Medical Practices New AI Clinical Assistant Capabilities, Automated Secondary and Tertiary Insurance Verification, and More